REDWOOD CITY, Calif., Jan. 25, 2016 -- Cardica, Inc. (Nasdaq:CRDC) today announced that it will release financial results for its fiscal second quarter ended December 31, 2015, on Thursday, February 4, 2016, after the markets close. Cardica’s management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company’s business.
Conference Call Details
To access the live conference call on February 4, 2016, at 4:30 p.m. Eastern Time via phone, please dial 800-901-5241 from the United States and Canada or 617-786-2963 internationally. The conference ID is 61547195. Please dial in approximately 10 minutes prior to the start of the call. A telephone replay will be available beginning approximately four hours after the call through February 11, 2016, and may be accessed by dialing 888-286-8010 from the United States and Canada or 617-801-6888 internationally. The replay passcode is 80216818.
To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company’s website at www.cardica.com. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
The webcast is also being distributed through the Thomson StreetEvents Network. Institutional investors can access the call via Thomson StreetEvents at www.streetevents.com, a password-protected event management site.
About Cardica
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and minimally invasive surgical procedures. Cardica's technology portfolio is intended to reduce operating time and facilitate minimally invasive and robot-assisted surgeries. Cardica’s MicroCutter XCHANGE® 30, that includes a cartridge-based articulating surgical stapling device with a five-millimeter shaft diameter and staples, is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine and the transection of the appendix. The MicroCutter XCHANGE 30 White Cartridge staple has application in vascular tissue. In addition, Cardica manufactures and markets its automated anastomosis systems, the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 56,500 units throughout the world.
Contact: Bob Newell Vice President, Finance and Chief Financial Officer (650) 331-7133 [email protected]


Apple Intelligence China Approval Lifts Alibaba and Baidu Shares
Nvidia Partners With Fanuc and Yaskawa to Accelerate AI Robotics in Japan
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI
Sodexo Unveils Shift & Grow 2030 Strategy, Targets Over 5% Revenue Growth by Fiscal 2030
NY Times Challenges Trump Administration Subpoenas Over Air Force One Report
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
United Airlines Beats Q2 Earnings, Raises 2026 Profit Outlook Despite Higher Fuel Costs
UBS Boosts China Tech Bets, Adds Kuaishou and Meituan to Focus List
Airbus Signs Cloud Deal With Scaleway to Power Secure AI and Defense Applications
Uber to Acquire Delivery Hero in $14.8 Billion Deal to Expand Global Food Delivery Business
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features
ASML Raises 2026 Outlook as AI Chip Demand Lifts Q2 Earnings 



